Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Sector Update: Healthcare Stocks Gain Friday Afternoon

Sector Update: Healthcare Stocks Gain Friday Afternoon

MT newswireMT newswire2026/10/09 17:50

01:50 PM EDT, 10/09/2026 (MT Newswires) -- Healthcare stocks rose Friday afternoon, with the NYSE Healthcare Index up 1.2% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.6%. The iShares Biotechnology ETF (IBB) climbed 3%. In corporate news, Humana (HUM) shares surged nearly 12% after it affirmed its full-year 2026 guidance of at least $9 in adjusted earnings per common share. Humana also said Friday that 95% of its Medicare Advantage members are enrolled in plans with ratings of at least four stars by the Centers for Medicare and Medicaid Services for 2027, which it called a "significant improvement." Shares of Moderna (MRNA) and other vaccine developers rose after The New York Times reported that the US National Institutes of Health is part of a public-private partnership to accelerate the development of cancer vaccines. Moderna shares jumped 12%. Merck (MRK), Novavax (NVAX) and BioNTech (BNTX) shares were up 3%, 15% and 5.2%, respectively. Vaxcyte (PCVX) and Vir Biotechnology (VIR) shares popped nearly 9% and 6%, respectively. TRex Bio (TRXB) shares were down 2.5% after the company's Nasdaq debut. The biotech company priced its initial public offering of around 8.3 million common shares at $14 apiece for gross proceeds of $116.7 million.

01:50 PM EDT, 10/09/2026 (MT Newswires) -- Healthcare stocks rose Friday afternoon, with the NYSE Healthcare Index up 1.2% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.6%. The iShares Biotechnology ETF (IBB) climbed 3%. In corporate news, Humana (HUM) shares surged nearly 12% after it affirmed its full-year 2026 guidance of at least $9 in adjusted earnings per common share. Humana also said Friday that 95% of its Medicare Advantage members are enrolled in plans with ratings of at least four stars by the Centers for Medicare and Medicaid Services for 2027, which it called a "significant improvement." Shares of Moderna (MRNA) and other vaccine developers rose after The New York Times reported that the US National Institutes of Health is part of a public-private partnership to accelerate the development of cancer vaccines. Moderna shares jumped 12%. Merck (MRK), Novavax (NVAX) and BioNTech (BNTX) shares were up 3%, 15% and 5.2%, respectively. Vaxcyte (PCVX) and Vir Biotechnology (VIR) shares popped nearly 9% and 6%, respectively. TRex Bio (TRXB) shares were down 2.5% after the company's Nasdaq debut. The biotech company priced its initial public offering of around 8.3 million common shares at $14 apiece for gross proceeds of $116.7 million.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!